AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Lobbying client · Maryland · filed 2025 to 2026

$1,460,000 Reported spend

6 Filings counted

1 Firms hired

30 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (103667), not by name.

Firms hired 1

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS $1,460,000 6 filings

Bills named in these filings 30

HR 929
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

6 filings
S 266
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

6 filings
HR 1708
Rebuild America’s Health Care Schools Act of 2025

4 filings
HR 3164
Ensuring Community Access to Pharmacist Services Act

4 filings
HR 4581
340B PATIENTS Act of 2025

4 filings
S 1087
Rebuild America’s Health Care Schools Act of 2025

4 filings
S 1954
Biosimilar Red Tape Elimination Act

4 filings
S 2372
340B PATIENTS Act of 2025

4 filings
S 2426
Equitable Community Access to Pharmacist Services Act

4 filings
HR 10225
Rebuild America’s Health Care Schools Act of 2024

2 filings
S 5397
Rebuild America’s Health Care Schools Act of 2024

2 filings
S 1784
MAPS Act

2 filings
HR 1561
ALERT Communities Act

1 filing
HR 1768
Lower Costs for Everyday Americans Act

1 filing
HR 2004
Tyler’s Law

1 filing
HR 3269
ETHIC Act

1 filing
HR 3514
Improving Seniors’ Timely Access to Care Act of 2025

1 filing
HR 3789
DTC Act of 2025

1 filing
HR 4122
Health Care for Energy Workers Act of 2025

1 filing
HR 5526
Biosimilar Red Tape Elimination Act

1 filing
HR 5880
Fight Illicit Pill Presses Act

1 filing
HR 6485
Skinny Labels, Big Savings Act

1 filing
HR 7184
PRESS Act

1 filing
HR 7994
HERO Act

1 filing
HR 8005
Stop Pills That Kill Act

1 filing
HR 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

1 filing
HR 9396
Prior Authorization Accountability Act

1 filing
HR 9661
Expedited Access to Biosimilars Act

1 filing
S 2658
Medication Affordability and Patent Integrity Act

1 filing
S 3014
Ensuring Timely Access to Generics Act of 2025

1 filing

Reported by year 2 years

2026 $500,000 2 filings
2025 $960,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 8

Centers For Medicare and Medicaid Services (CMS) 6
Drug Enforcement Administration (DEA) 6
Food & Drug Administration (FDA) 6
Health & Human Services, Dept of (HHS) 6
Health Resources & Services Administration (HRSA) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
White House Office 6

Recent filings 6 total

Q2

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $260,000 expenses · posted Jul 20, 2026

View → Q1

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $240,000 expenses · posted Apr 20, 2026

View → Q4

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $250,000 expenses · posted Jan 20, 2026

View → Q3

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $230,000 expenses · posted Oct 17, 2025

View → Q2

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $260,000 expenses · posted Jul 21, 2025

View → Q1

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $220,000 expenses · posted Apr 17, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.